Management of early breast cancer--the current approach.
This seventh article in our series on breast disease will focus on what is new in the management of invasive primary breast cancer. Up-to-date information on the key aspects of breast cancer management is presented, including descriptions of the new technique of sentinel lymph node biopsy and the new hormone treatment, aromatase inhibitors. Current trends in surgery for breast cancer and the adjuvant treatments of chemotherapy and radiotherapy are also discussed.
Brennan
Meagan
M
NSW Breast Cancer Institute, Westmead Hospital, New South Wales, Australia. meaganb@bci.org.au
Wilcken
Nicholas
N
French
James
J
Ung
Owen
O
Boyages
John
J
D047072:Aromatase Inhibitors / Q000627:therapeutic use; D001365:Axilla; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy*; D017024:Chemotherapy, Adjuvant / Q000379:methods; D005260:Female; D006694:Holistic Health; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods; D008408:Mastectomy / Q000379:methods; D009364:Neoplasm Recurrence, Local; D010348:Patient Care Team / Q000458:organization & administration; D018714:Radiotherapy, Adjuvant / Q000379:methods; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D013629:Tamoxifen / Q000627:therapeutic use
D047072:Aromatase Inhibitors; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen